Growth Metrics

Dexcom (DXCM) Research & Development (2010 - 2026)

Dexcom (DXCM) reported Research & Development of $145.3 million for Q1 2026, little changed year-over-year from $145.2 million in Q1 2025, and down 1.96% on a QoQ basis from $148.2 million in Q4 2025.

Dexcom (DXCM) has 17 years of Research & Development data on file, last reported at $145.3 million in Q1 2026.

  • Quarterly Research & Development changed 0.07% year-over-year to $145.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $599.2 million (up 7.75% YoY) and the FY2025 annual result came in at $599.1 million, up 8.45% from the prior year.
  • Research & Development fell to $145.3 million in Q1 2026 per DXCM's latest filing, from $148.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $157.5 million in Q3 2025 and bottomed at $110.3 million in Q3 2022.
  • The 5-year median for Research & Development is $136.0 million (2024), against an average of $134.5 million.
  • Peak annual rise in Research & Development reached 24.22% in 2022, while the deepest fall reached 22.36% in 2022.
  • Tracing DXCM's Research & Development over 5 years: stood at $116.3 million in 2022, then gained by 17.02% to $136.1 million in 2023, then climbed by 2.5% to $139.5 million in 2024, then rose by 6.24% to $148.2 million in 2025, then declined by 1.96% to $145.3 million in 2026.
  • Per Business Quant, the three latest DXCM Research & Development figures stand at $145.3 million (Q1 2026), $148.2 million (Q4 2025), and $157.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 767.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 413.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 722.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 263.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -461.27 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 345.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.80 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 103.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 145.30 Mn
Dec 31, 2025 148.20 Mn
Sep 30, 2025 157.50 Mn
Jun 30, 2025 148.20 Mn
Mar 31, 2025 145.20 Mn
Dec 31, 2024 139.50 Mn
Sep 30, 2024 135.40 Mn
Jun 30, 2024 136.00 Mn
Mar 31, 2024 141.50 Mn
Dec 31, 2023 136.10 Mn
Sep 30, 2023 131.40 Mn
Jun 30, 2023 119.30 Mn
Mar 31, 2023 119.00 Mn
Dec 31, 2022 116.30 Mn
Sep 30, 2022 110.30 Mn
Jun 30, 2022 121.70 Mn
Mar 31, 2022 135.90 Mn
Dec 31, 2021 149.80 Mn
Sep 30, 2021 128.80 Mn
Jun 30, 2021 129.10 Mn
Mar 31, 2021 109.40 Mn
Dec 31, 2020 119.20 Mn
Sep 30, 2020 87.70 Mn
Jun 30, 2020 79.90 Mn
Mar 31, 2020 73.10 Mn
Dec 31, 2019 78.80 Mn
Sep 30, 2019 66.70 Mn
Jun 30, 2019 69.00 Mn
Mar 31, 2019 59.00 Mn
Dec 31, 2018 57.60 Mn
Sep 30, 2018 50.10 Mn
Jun 30, 2018 47.20 Mn
Mar 31, 2018 44.80 Mn
Dec 31, 2017 48.70 Mn
Sep 30, 2017 43.30 Mn
Jun 30, 2017 45.30 Mn
Mar 31, 2017 48.10 Mn
Dec 31, 2016 43.70 Mn
Sep 30, 2016 43.90 Mn
Jun 30, 2016 36.30 Mn
Mar 31, 2016 32.20 Mn
Dec 31, 2015 28.50 Mn
Sep 30, 2015 64.80 Mn
Jun 30, 2015 24.40 Mn
Mar 31, 2015 19.80 Mn
Dec 31, 2014 21.60 Mn
Sep 30, 2014 18.50 Mn
Jun 30, 2014 14.80 Mn
Mar 31, 2014 14.50 Mn
Dec 31, 2013 12.60 Mn
Sep 30, 2013 11.80 Mn
Jun 30, 2013 11.10 Mn
Mar 31, 2013 9.30 Mn
Dec 31, 2012 8.60 Mn
Sep 30, 2012 10.30 Mn
Jun 30, 2012 10.00 Mn
Mar 31, 2012 9.40 Mn
Dec 31, 2011 8.09 Mn
Sep 30, 2011 8.23 Mn
Jun 30, 2011 7.02 Mn
Mar 31, 2011 6.27 Mn
Dec 31, 2010 6.88 Mn
Sep 30, 2010 6.16 Mn
Jun 30, 2010 5.43 Mn